AlloArc Pulmonology Note (Standard)
About this template
Sample note
Chief Complaints:
COPD follow-up.
Worsening exertional breathlessness.
Lung nodule follow-up.
HPI:
71-year-old male with a past medical history of COPD, chronic hypoxemic respiratory failure on home oxygen, solitary pulmonary nodule, and coronary artery disease status post stent 2018, presents to pulmonology for COPD follow-up.
1. COPD / CHRONIC HYPOXEMIC RESPIRATORY FAILURE:
- Breathing improved after the September ER visit but not back to baseline. Must stop after walking from the house to the mailbox, about half a block; previously reached the end of the street. Walking tolerance declined around June 2026.
- Morning cough for years, now with more sputum, about 2 tablespoons each morning, white with occasional early yellow sputum. Sleeps on two pillows as longstanding practice and sometimes wakes coughing; denies hemoptysis, fever, chest pain, or leg swelling.
- Urgent care 08/03/2026 treated a COPD flare with prednisone 40 mg daily for 5 days and azithromycin. Bayou Teche Medical Center ER 09/22/2026 treated with nebulizers, prednisone 40 mg daily for 5 days, and doxycycline 100 mg twice daily for 7 days; discharged that night without admission.
- Taking Trelegy Ellipta 100/62.5/25 mcg one inhalation every morning and rinsing afterward, without recurrent thrush. Albuterol HFA use increased from about three times weekly to three or four times daily.
- Current oxygen prescription is 2 L/min by nasal cannula with exertion and sleep; patient uses 3 L/min walking in the yard because 2 is insufficient and 2 L/min at night. Home oxygen saturation while walking 86-87% on 2 L/min and 91-92% on 3 L/min. Portable concentrator is heavy but works, with about 2 hours of battery life at 3 L/min.
- Wife still smokes, mostly on the porch.
- Post-bronchodilator spirometry 10/14/2026: FEV1 1.18 L (42% predicted), FVC 2.74 L (71% predicted), FEV1/FVC 0.43; FEV1 1.26 L (45% predicted) 09/10/2025. ER absolute eosinophils 09/22/2026: 340 cells/microliter; ECG that date: QTc 482 ms.
2. LUNG NODULE:
- CT chest without contrast 03/18/2026 showed a 6 mm solid right upper lobe nodule; radiology recommended follow-up CT in 6 to 12 months. Worried whether the nodule is cancer.
3. CORONARY ARTERY DISEASE:
- Saw cardiology (Dr. Hebert) in July 2026; told his heart was doing well, with follow-up in a year.
4. FORMER TOBACCO USE:
- Quit in 2019; 45 pack-year history; remains abstinent.
Review of Systems:
Constitutional: Denies fever.
Mouth/Throat: Denies current thrush.
Cardiovascular: Denies chest pain or leg swelling.
Respiratory: Reports exertional shortness of breath, productive cough, and nighttime cough. Denies coughing up blood.
Assessment:
ICD J44.9-Chronic obstructive pulmonary disease, unspecified:
ICD J96.11-Chronic respiratory failure with hypoxia:
ICD R91.1-Solitary pulmonary nodule:
ICD I25.10-Atherosclerotic heart disease of native coronary artery without angina pectoris:
ICD Z87.891-Personal history of nicotine dependence:
Treatment/Plan:
ICD J44.9-Chronic obstructive pulmonary disease, unspecified:
- Started roflumilast 250 micrograms once daily for four weeks, then 500 micrograms once daily, for two recent flares despite Trelegy with daily cough and sputum. Spirometry 10/14/2026 showed post-bronchodilator FEV1 1.18 L (42% predicted), FVC 2.74 L (71% predicted), FEV1/FVC 0.43, slightly lower than 09/10/2025 with persistent severe obstruction; scattered end-expiratory wheezes and reduced air movement on exam today.
- Deferred long-term azithromycin given QTc 482 ms on the ER ECG 09/22/2026 and coronary artery disease.
- Continued Trelegy Ellipta 100/62.5/25 mcg one inhalation daily; eosinophils 340 cells/microliter (09/22/2026) support continuing the inhaled corticosteroid.
- Continued albuterol HFA 90 mcg two inhalations every 4 to 6 hours as needed.
- Counseled on loose stools, nausea, and weight loss with roflumilast; advised weight monitoring and calling for more than about five pounds lost, with weight 164 lb today.
- Offered pulmonary rehabilitation; patient declined for now because transportation to Lafayette twice weekly is unavailable. Advised notifying the office if access changes.
- Prescribed home rescue pack of prednisone 40 mg daily for 5 days and doxycycline 100 mg twice daily for 5 days, to start for green sputum or increased breathlessness lasting more than a day and call the office that same day.
- Follow-up in six weeks to assess roflumilast tolerance and review CT.
- Prior studies: CT chest without contrast 03/18/2026: moderate upper-lobe-predominant centrilobular emphysema.
- Prior studies: Alpha-1 antitrypsin 2021: 142 mg/dL, phenotype MM.
- Prior therapies tried and failed: Anoro Ellipta 2022 to 2023 (continued exacerbations); Breo Ellipta 2021 to 2022 (recurrent oral thrush).
- Background: RSV and influenza vaccines received around September 2026.
ICD J96.11-Chronic respiratory failure with hypoxia:
- Office oxygen assessment: room air at rest 91%, room air with ambulation 85%, 2 L/min with ambulation 88%, 3 L/min with ambulation 93%; changed oxygen prescription to 3 L/min with exertion and retained 2 L/min for sleep.
- Counseled on serious fire risk from smoking around oxygen: no smoking in the house or within ten feet of tubing or concentrator.
- Advised ED evaluation for breathlessness at rest, inability to finish a sentence, or oxygen saturation remaining under 88% on 3 L/min.
ICD R91.1-Solitary pulmonary nodule:
- Ordered CT chest without contrast for November 2026 surveillance of the 6 mm solid right upper lobe nodule on CT 03/18/2026, within the recommended 6-to-12-month window.
- Discussed that the nodule is being monitored because of his smoking history and has not been diagnosed as cancer.
ICD I25.10-Atherosclerotic heart disease of native coronary artery without angina pectoris:
- Background: Coronary stent 2018.
ICD Z87.891-Personal history of nicotine dependence:
This sample note was written by the template’s author and screened for patient information before publishing. Actual output may vary depending on patient encounter and clinical context.